Director, Global Medical Affairs Technology

Alnylam is the world’s leading RNA interference (RNAi) company, dedicated to transforming the lives of patients through innovative medicines. As Medical Affairs becomes increasingly data-driven, insight-led, and outcomes-focused, Alnylam is advancing a platform- and data-first technology operating model to enable scale, simplification, and enterprise alignment. The Director, Global Medical Affairs Technology is accountable for the strategy, roadmap, lifecycle, and governance of the platforms, data products, and integrations that enable Global Medical Affairs. This role serves as the primary technology leader and business partner for Medical Affairs across field medical, medical insights, omnichannel scientific engagement, medical information, scientific communications, KOL/HCP engagement, and real-world evidence enablement. This is an individual contributor role that will partner closely with Medical Affairs, Data & AI, Security, Privacy/Compliance, external partners, and contractors as needed to simplify the technology landscape, strengthen data foundations, and deliver scalable, governed, reusable capabilities that improve scientific exchange, insight generation, and medical impact measurement worldwide.

Strategy & Business Partnership · Own the Medical Affairs technology strategy and portfolio by serving as the primary technology leader and trusted business partner to Global Medical Affairs, translating business priorities across field medical, medical insights, omnichannel engagement, medical information, scientific communications, KOL/HCP engagement, and RWE into a clear, enterprise-aligned technology roadmap. Product, Platform & Data Leadership · Own product and platform lifecycle management for Medical Affairs technology capabilities, including roadmap, standards, architecture principles, lifecycle planning, and governance, ensuring platforms are scalable, compliant, reusable, and aligned with enterprise technology and data strategy. · Define and govern the Medical Affairs data strategy in partnership with Data & AI, including data ingestion, integration, reusable data assets, governed access, analytics enablement, and measurement frameworks that support medical insights generation, longitudinal analysis, RWE, and decision support. Omnichannel, Field Medical & Scientific Engagement Enablement · Enable connected, compliant scientific engagement by building the technology and data foundation that links content, interactions, and insights across MSL/MOSL engagement, scientific communications, medical information, medical web and digital channels, and broader omnichannel medical capabilities. · Advance simplification and reuse across the Medical Affairs ecosystem by reducing fragmentation, manual work, siloed reporting, and bespoke solutions, while promoting shared platforms, standardized data products, and enterprise-aligned design patterns. Delivery, Adoption & Value Realization · Partner on intake, prioritization, and cross-functional delivery for Medical Affairs technology investments, working with Medical Operations & Insights and other Medical Affairs stakeholders to translate business needs into platform capabilities, roadmap decisions, and measurable releases that improve user experience, operational efficiency, and business outcomes. · Jointly define adoption, performance, and value realization measures with Medical Operations & Insights, Data & AI, and business stakeholders by establishing KPIs, monitoring usage and platform health, and using evidence to refine priorities, communicate impact, and ensure Medical Affairs technology investments deliver measurable value. Operations, Governance & Vendor Leadership · Govern operations, compliance, and vendor performance to ensure Medical Affairs platforms and data products are reliable, secure, auditable, and well-supported, with strong accountability for privacy, security, documentation, quality, service delivery, and partner